Hannah Valantine Care Dx, Inc. (CDNA) insider trading activity

Hannah Valantine is of CareDx, Inc.. Currently has a direct ownership of 38,994 shares of CDNA, which is worth approximately $790,798. The most recent transaction as insider was on Jun 18, 2025, when has been sold 10,570 shares (Common Stock) at a price of $19.16 per share, resulting in proceeds of $202,521. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39K

4.09% 3M change

4.09% 12M change

Total Value Held $790,798

Hannah Valantine Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 18 2025	SELL Open market or private sale	$202,521 $19.16 p/Share	10,570 Reduced 21.33%	38,994 Common Stock
Jun 13 2025	BUY Grant, award, or other acquisition	-	12,103 Added 19.63%	49,564 Common Stock
Jun 14 2024	BUY Grant, award, or other acquisition	-	10,570 Added 22.01%	37,461 Common Stock
Jun 16 2023	BUY Grant, award, or other acquisition	-	18,844 Added 41.2%	26,891 Common Stock
Jan 06 2023	BUY Grant, award, or other acquisition	-	676 Added 7.75%	8,047 Common Stock
Oct 04 2022	BUY Grant, award, or other acquisition	-	422 Added 5.42%	7,371 Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	325 Added 4.47%	6,949 Common Stock
Jun 16 2022	BUY Grant, award, or other acquisition	-	4,863 Added 42.33%	6,624 Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	131 Added 6.92%	1,761 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	-	1,630 Added 50.0%	1,630 Common Stock

Also insider at

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Healthcare

Director

BBIO

BridgeBio Pharma, Inc. Healthcare